Screening compound: InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3

Screening compound: InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3
Screening compound: InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5408-0121

Molecular Formula

C20H17N3O3 (C20 H17 N3 O3)

Compound Name

(E)-1-(3,4-dimethoxyphenyl)-N-[2-(furan-2-yl)imidazo[1,2-a]pyridin-3-yl]methanimine

IUPAC name

(E)-1-(34-dimethoxyphenyl)-N-[2-(furan-2-yl)imidazo[12-a]pyridin-3-yl]methanimine

SMILES

COc(ccc(/C=N/c1c(-c2ccco2)nc2n1cccc2)c1)c1OC

InChI

InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3

InChI Key

DJDHTRULUUTXOC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00363252

InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Antiviral Annotated Library (21441 compounds)

CNS Annotated Library (688 compounds)

Human GPCR Annotated Library (5539 compounds)

Human Receptors Annotated Library (5376 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Covalent Inhibitors Library (7986 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3?
Check Price and Availability of InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C20H17N3O3/c1-24-15-9-8-14(12-17(15)25-2)13-21-20-19(16-6-5-11-26-16)22-18-7-3-4-10-23(18)20/h3-13H,1-2H3 available by request